Northwest Biotherapeutics
$0.170000
91
+$0.00+0.89%Friday 19:59
Statistics
Day High
0.1774
Day Low
0.166
52W High
0.34
52W Low
0.14
Volume
1,111,045
Avg. Volume
4,088,201
Mkt Cap
283.78M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Nov 9Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.03
0.03
0.08
0.14
Expected EPS
N/A
Actual EPS
-0.03
Financials
-4,461.32%Profit Margin
Unprofitable1.38MRevenue
-61.48MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NWBO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Marker Therapeutics
MRKR
Mkt Cap17.51M
Novartis
NVS
Mkt Cap303.67B
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Moderna
MRNA
Mkt Cap88.52B
Pfizer
PFE
Mkt Cap173.95B
Astrazeneca
AZN
Mkt Cap289.48B
About
Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulate their immune system to combat cancerous cells. The company's leading therapeutic candidate, DCVax-L, has successfully completed Phase III clinical trials targeting Glioblastoma multiforme, an aggressive form of brain cancer. Additionally, Northwest Biotherapeutics is progressing DCVax-Direct through Phase I/II clinical studies, focusing on the treatment of inoperable solid tumors. Founded in 1996, the company's headquarters are situated in Bethesda, Maryland.
Show More
CEO
Linda F. Powers
Employees
105
Country
United States
ISIN
US66737P6007
Listings
0 Comments
Share your thoughts
FAQs
What is Northwest Biotherapeutics stock price today?▼
The current price of NWBO is $0.17 USD — it has increased by +0.89% in the past 24 hours. Watch Northwest Biotherapeutics stock price performance more closely on the chart.
What is Northwest Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Northwest Biotherapeutics stocks are traded under the ticker NWBO.
Is Northwest Biotherapeutics stock price growing?▼
NWBO stock has risen by +1.6% compared to the previous week, the month change is a +13.26% rise, over the last year Northwest Biotherapeutics has showed a -31.78% decrease.
What is Northwest Biotherapeutics market cap?▼
Today Northwest Biotherapeutics has the market capitalization of 283.78M
What were Northwest Biotherapeutics earnings last quarter?▼
NWBO earnings for the last quarter are -0.03 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Northwest Biotherapeutics revenue for the last year?▼
Northwest Biotherapeutics revenue for the last year amounts to 1.38M USD.
What is Northwest Biotherapeutics net income for the last year?▼
NWBO net income for the last year is -61.48M USD.
How many employees does Northwest Biotherapeutics have?▼
As of November 2, 2026, the company has 105 employees.
In which sector is Northwest Biotherapeutics located?▼
Northwest Biotherapeutics operates in the Health & Wellness sector.
When did Northwest Biotherapeutics complete a stock split?▼
The last stock split for Northwest Biotherapeutics was on September 26, 2012 with a ratio of 1:16.
Where is Northwest Biotherapeutics headquartered?▼
Northwest Biotherapeutics is headquartered in Bethesda, United States.